603998 方盛制药
午间休市 08-01 11:29:56
资讯
新帖
简况
化妆品概念盘中跳水,方盛制药跌0.35%
市场透视 · 07-31 06:32
化妆品概念盘中跳水,方盛制药跌0.35%
千金藤素概念盘中跳水,皓元医药跌8.45%
市场透视 · 07-30 05:52
千金藤素概念盘中跳水,皓元医药跌8.45%
高血压概念盘中跳水,方盛制药跌0.97%
市场透视 · 07-30 01:51
高血压概念盘中跳水,方盛制药跌0.97%
普惠育儿补贴落地 母婴概念股集体爆发
深圳商报 · 07-29 17:09
普惠育儿补贴落地 母婴概念股集体爆发
方盛制药涨5.08% 创近8个月新高 政策红利与估值切换驱动
智选洞察 · 07-29 05:05
方盛制药涨5.08% 创近8个月新高 政策红利与估值切换驱动
高血压概念盘中跳水,乐心医疗跌1.15%
市场透视 · 07-29
高血压概念盘中跳水,乐心医疗跌1.15%
方盛制药中药创新药研发进展顺利,玄七健骨片年销破亿
DoNews · 07-27
方盛制药中药创新药研发进展顺利,玄七健骨片年销破亿
方盛制药:注射用迪安替康钠正处于临床研究阶段
互动易 · 07-25
方盛制药:注射用迪安替康钠正处于临床研究阶段
方盛制药:公司将深入推进“自研+引进+混合”的多元研发模式
互动易 · 07-25
方盛制药:公司将深入推进“自研+引进+混合”的多元研发模式
方盛制药:业务正在拓展中经营成果存在不确定性
互动易 · 07-25
方盛制药:业务正在拓展中经营成果存在不确定性
高血压概念盘中跳水,方盛制药跌0.74%
市场透视 · 07-23
高血压概念盘中跳水,方盛制药跌0.74%
方盛制药最新公告:拟将“强力枇杷露”药品品种所有权转让给康普药业
证券之星 · 07-22
方盛制药最新公告:拟将“强力枇杷露”药品品种所有权转让给康普药业
民营医院概念盘中跳水,方盛制药跌0.09%
市场透视 · 07-22
民营医院概念盘中跳水,方盛制药跌0.09%
千金藤素概念盘中跳水,方盛制药跌1.79%
市场透视 · 07-18
千金藤素概念盘中跳水,方盛制药跌1.79%
方盛制药中标药品阳光采购项目 券商看好买入评级助推股价上涨
自选股中标信息 · 07-17
方盛制药中标药品阳光采购项目 券商看好买入评级助推股价上涨
方盛制药涨5.13%创近一个月新高 创新转型构筑估值护城河
智选洞察 · 07-16
方盛制药涨5.13%创近一个月新高 创新转型构筑估值护城河
眼科医疗概念盘中拉升,方盛制药涨5.13%
市场透视 · 07-16
眼科医疗概念盘中拉升,方盛制药涨5.13%
千金藤素概念盘中拉升,理邦仪器涨4.82%
市场透视 · 07-16
千金藤素概念盘中拉升,理邦仪器涨4.82%
千金藤素概念盘中拉升,步长制药涨3.55%
市场透视 · 07-14
千金藤素概念盘中拉升,步长制药涨3.55%
华创医药投资观点&研究专题周周谈第134期:中药企业的创新布局
华创证券 · 07-11
华创医药投资观点&研究专题周周谈第134期:中药企业的创新布局
加载更多
公司概况
公司名称:
湖南方盛制药股份有限公司
所属行业:
医药制造业
上市日期:
2014-12-05
主营业务:
湖南方盛制药股份有限公司的主营业务是从事医药产品的研发、生产和销售。公司的主要产品是心脑血管疾病用药、抗感染用药、呼吸系统用药、儿童用药、妇科疾病用药、骨骼肌肉系统用药。公司先后获评:国家火炬计划重点高新技术企业、国家级守合同重信用企业、国家博士后科研工作站、国家企业技术中心、湖南省示范性医药企业、湖南省小巨人计划企业;荣获“国家绿色工厂”称号。
发行价格:
14.85
{"stockData":{"symbol":"603998","market":"SH","secType":"STK","nameCN":"方盛制药","latestPrice":11.54,"timestamp":1754018996000,"preClose":11.37,"halted":0,"volume":19210440,"delay":0,"changeRate":0.015,"floatShares":438999999,"shares":438999999,"eps":0.6224,"marketStatus":"午间休市","change":0.17,"latestTime":"08-01 11:29:56","open":11.32,"high":11.72,"low":11.26,"amount":221000000,"amplitude":0.0405,"askPrice":11.54,"askSize":38,"bidPrice":11.52,"bidSize":739,"shortable":0,"etf":0,"ttmEps":0.6224,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1754024400000},"marketStatusCode":3,"adr":0,"adjPreClose":11.37,"symbolType":"stock","openAndCloseTimeList":[[1754011800000,1754019000000],[1754024400000,1754031600000]],"highLimit":12.51,"lowLimit":10.23,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":439081360,"isCdr":false,"pbRate":3,"roa":"--","peRate":18.541131,"roe":"5.32%","epsLYR":0.59,"committee":0.374423,"marketValue":5067000000,"turnoverRate":0.0438,"status":0,"floatMarketCap":5067000000},"requestUrl":"/m/hq/s/603998","defaultTab":"news","newsList":[{"id":"2555006086","title":"化妆品概念盘中跳水,方盛制药跌0.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2555006086","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555006086?lang=zh_cn&edition=full","pubTime":"2025-07-31 14:32","pubTimestamp":1753943552,"startTime":"0","endTime":"0","summary":"07月31日,化妆品概念盘中跳水,截至14点32分,化妆品概念整体指数下跌1.03%,报1704.580点。从个股上来看,该概念的成分股中,方盛制药跌0.35%,跌幅居前。从资金上来看,截止发稿,化妆品概念概念主力净流入为-2.34亿,其中常山药业受到资金热捧,主力净流入2.39亿;拉长时间线来看,该板块近20日主力资金净流入-48.72亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025073114323294c57eb3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025073114323294c57eb3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","603998","BK0060"],"gpt_icon":0},{"id":"2555097860","title":"千金藤素概念盘中跳水,皓元医药跌8.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2555097860","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555097860?lang=zh_cn&edition=full","pubTime":"2025-07-30 13:52","pubTimestamp":1753854764,"startTime":"0","endTime":"0","summary":"07月30日,千金藤素概念盘中跳水,截至13点52分,千金藤素概念整体指数下跌1.10%,报1133.070点。从个股上来看,该概念的成分股中,皓元医药跌8.45%,阿拉丁、优宁维、方盛制药跌幅居前。从资金上来看,截止发稿,千金藤素概念主力净流入为-9233.22万,其中云南白药受到资金热捧,主力净流入1182.32万;拉长时间线来看,该板块近20日主力资金净流入9502.41万。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730135244a6c90ffe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730135244a6c90ffe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688131","688179","603998","BK0216"],"gpt_icon":0},{"id":"2555909374","title":"高血压概念盘中跳水,方盛制药跌0.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2555909374","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555909374?lang=zh_cn&edition=full","pubTime":"2025-07-30 09:51","pubTimestamp":1753840282,"startTime":"0","endTime":"0","summary":"07月30日,高血压概念盘中跳水,截至09点51分,高血压概念整体指数下跌0.50%,报1658.540点。从个股上来看,该概念的成分股中,方盛制药跌0.97%,恒瑞医药、乐心医疗、向日葵跌幅居前。从资金上来看,截止发稿,高血压概念主力净流入为-1.20亿,其中润都股份受到资金热捧,主力净流入655.36万;拉长时间线来看,该板块近20日主力资金净流入3.07亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730095122a6c8b58f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730095122a6c8b58f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603998","BK0060","01276","BK0239","600276"],"gpt_icon":0},{"id":"2555634360","title":"普惠育儿补贴落地 母婴概念股集体爆发","url":"https://stock-news.laohu8.com/highlight/detail?id=2555634360","media":"深圳商报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555634360?lang=zh_cn&edition=full","pubTime":"2025-07-30 01:09","pubTimestamp":1753808940,"startTime":"0","endTime":"0","summary":"7月29日,母婴概念股集体爆发。消息面上,7月28日,《育儿补贴制度实施方案》公布。根据数据,A股母婴股已经历了连续4年的调整期,近4年来,康希诺股价累计下跌86.61%,贝泰妮、康泰医学股价下跌超七成,良品铺子、华大基因、孩子王等跌超三成。市场人士指出,随着支持政策的相继出台,母婴消费市场或将出现转机。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507300114379725d8f8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507300114379725d8f8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600684","603998","603839","BK0253"],"gpt_icon":0},{"id":"2555084247","title":"方盛制药涨5.08% 创近8个月新高 政策红利与估值切换驱动","url":"https://stock-news.laohu8.com/highlight/detail?id=2555084247","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555084247?lang=zh_cn&edition=full","pubTime":"2025-07-29 13:05","pubTimestamp":1753765524,"startTime":"0","endTime":"0","summary":"方盛制药股价今日表现强势,截至13点04分,最新价报11.37元/股,上涨5.08%,创近8个月新高。政策博弈与估值切换驱动短期波动方盛制药近期股价波动与资金高频调仓密切相关。但中药材价格指数回落及创新药集采豁免政策形成对冲效应,吸引部分资金在估值洼地布局。研发护城河与政策红利支撑价值重估方盛制药长期成长性由研发积累与行业集中度提升双重驱动。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729130526a468ee42&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729130526a468ee42&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0060","603998","BK0239"],"gpt_icon":0},{"id":"2555882510","title":"高血压概念盘中跳水,乐心医疗跌1.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2555882510","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555882510?lang=zh_cn&edition=full","pubTime":"2025-07-29 09:36","pubTimestamp":1753752973,"startTime":"0","endTime":"0","summary":"07月29日,高血压概念盘中跳水,截至09点36分,高血压概念整体指数下跌1.16%,报1618.540点。从个股上来看,该概念的成分股中,乐心医疗跌1.15%,润都股份、方盛制药、普洛药业跌幅居前。从资金上来看,截止发稿,高血压概念主力净流入为-2.25亿,其中信立泰受到资金热捧,主力净流入654.43万;拉长时间线来看,该板块近20日主力资金净流入10.83亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729093613a46894c8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729093613a46894c8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["300562","BK0109","BK0114","BK0239","603998","BK0251","BK0060"],"gpt_icon":0},{"id":"2554010748","title":"方盛制药中药创新药研发进展顺利,玄七健骨片年销破亿","url":"https://stock-news.laohu8.com/highlight/detail?id=2554010748","media":"DoNews","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554010748?lang=zh_cn&edition=full","pubTime":"2025-07-27 20:18","pubTimestamp":1753618683,"startTime":"0","endTime":"0","summary":"2025年7月18日,方盛制药接待首创证券调研,披露中药创新药研发进展。公司聚焦骨科、心脑血管科等慢病领域,目前有7个中药创新药项目处于临床前研究。在研药物健胃祛痛丸进入三期临床试验,紫英颗粒与止血消痛颗粒已提交临床试验注册申请,小儿荆杏止咳颗粒新增成人适应症。其中,玄七健骨片上市次年销售额突破1亿元,2025年第一季度销量同比增长超90%,成为核心增长动力。公司采取“创新药+集采药”双轮驱动策略,持续推动中药创新药管线扩充。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250727202122972150b1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250727202122972150b1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["159992","BK0060","BK0239","561510","562390","603998"],"gpt_icon":0},{"id":"2554752896","title":"方盛制药:注射用迪安替康钠正处于临床研究阶段","url":"https://stock-news.laohu8.com/highlight/detail?id=2554752896","media":"互动易","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554752896?lang=zh_cn&edition=full","pubTime":"2025-07-25 15:33","pubTimestamp":1753428786,"startTime":"0","endTime":"0","summary":"有投资者向方盛制药提问, 贵公司治疗癌症的创新药,已经用在临床了吧?另外在国家立项的治疗肝炎的药已经研发出来了吗?公司回答表示,尊敬的投资者,您好!公司参股子公司湖南方盛华美医药科技有限公司研究用于治疗晚期结肠癌的注射用迪安替康钠正处于临床研究阶段;公司研究用于治疗联合化疗失败的转移性乳腺癌或辅助化疗后6个月内复发的乳腺癌的注射用紫杉醇(白蛋白结合型)已完成BE试验;用于转移性胰腺癌的伊立替康脂质体注射液正处于药学研究中。上述信息已经在公司年报中披露,研发项目总体情况参见公司年报,感谢您对公司的关注!敬请注意投资风险。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250725153628a6c12901&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250725153628a6c12901&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0060","BK0239","603998"],"gpt_icon":0},{"id":"2554752842","title":"方盛制药:公司将深入推进“自研+引进+混合”的多元研发模式","url":"https://stock-news.laohu8.com/highlight/detail?id=2554752842","media":"互动易","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554752842?lang=zh_cn&edition=full","pubTime":"2025-07-25 15:33","pubTimestamp":1753428786,"startTime":"0","endTime":"0","summary":"公司将深入推进“自研+引进+混合”的多元研发模式,在各细分领域全面布局,全力推动公司的创新发展进程;持续发挥“融系”公司的资源整合优势,不断加强研发平台建设,吸引高端人才,全面提升研发效率与创新竞争力,进一步丰富中药创新药、化学仿制药、原料药研发产品管线,为打造具备持续竞争力的产品集群战略布局打下坚实基础。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250725153635a6c12914&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250725153635a6c12914&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","603998","BK0060"],"gpt_icon":0},{"id":"2554752384","title":"方盛制药:业务正在拓展中经营成果存在不确定性","url":"https://stock-news.laohu8.com/highlight/detail?id=2554752384","media":"互动易","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554752384?lang=zh_cn&edition=full","pubTime":"2025-07-25 15:33","pubTimestamp":1753428783,"startTime":"0","endTime":"0","summary":"有投资者向方盛制药提问, 公司的孙公司中南范雅细胞医疗科技(深圳)有限公司主营细胞医疗,请问在细胞医疗领域,中南范雅目前拥有哪些核心技术和专利?公司回答表示,尊敬的投资者,您好!中南范雅细胞医疗科技(深圳)有限公司为公司控股子公司湖南湘雅制药有限公司之全资子公司湖南中方雅盛健康产业投资有限公司持股51%之控股子公司(注册资本100万元,2024年2月成立,另一持股49%的股东为范奢健康管理(深圳)有限公司 ),属于初创型公司,业务正在拓展中,经营成果存在不确定性。感谢您对公司的关注!敬请注意投资风险。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072515362894ba08d0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072515362894ba08d0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603998","BK0239","BK0060"],"gpt_icon":0},{"id":"2553260079","title":"高血压概念盘中跳水,方盛制药跌0.74%","url":"https://stock-news.laohu8.com/highlight/detail?id=2553260079","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553260079?lang=zh_cn&edition=full","pubTime":"2025-07-23 09:41","pubTimestamp":1753234864,"startTime":"0","endTime":"0","summary":"07月23日,高血压概念盘中跳水,截至09点41分,高血压概念整体指数下跌1.06%,报1578.240点。从个股上来看,该概念的成分股中,方盛制药跌0.74%,向日葵、鱼跃医疗、立方制药跌幅居前。从资金上来看,截止发稿,高血压概念主力净流入为-5115.74万,其中一品红受到资金热捧,主力净流入1222.64万;拉长时间线来看,该板块近20日主力资金净流入5.02亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072309410497b1862d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072309410497b1862d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","603998","BK0060"],"gpt_icon":0},{"id":"2553239399","title":"方盛制药最新公告:拟将“强力枇杷露”药品品种所有权转让给康普药业","url":"https://stock-news.laohu8.com/highlight/detail?id=2553239399","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553239399?lang=zh_cn&edition=full","pubTime":"2025-07-22 17:23","pubTimestamp":1753176185,"startTime":"0","endTime":"0","summary":"方盛制药(603998.SH)公告称,公司及全资子公司滕王阁药业与康普药业签订《药品上市许可转让协议》,将“强力枇杷露”药品品种的所有权以不低于公司成本价的价格转让给康普药业,交易金额在董事长审批权限范围内。此次交易旨在提高资产运营效率,并展开战略合作。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025072200027933.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0060","BK0239","603998"],"gpt_icon":0},{"id":"2553285853","title":"民营医院概念盘中跳水,方盛制药跌0.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2553285853","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553285853?lang=zh_cn&edition=full","pubTime":"2025-07-22 10:24","pubTimestamp":1753151096,"startTime":"0","endTime":"0","summary":"07月22日,民营医院概念盘中跳水,截至10点24分,民营医院概念整体指数下跌1.06%,报1951.030点。从个股上来看,该概念的成分股中,方盛制药跌0.09%,跌幅居前。从资金上来看,截止发稿,民营医院概念主力净流入为-3.33亿,其中兴齐眼药受到资金热捧,主力净流入4012.14万;拉长时间线来看,该板块近20日主力资金净流入-49.34亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250722102456954c1a53&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250722102456954c1a53&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0060","BK0239","603998"],"gpt_icon":0},{"id":"2552453596","title":"千金藤素概念盘中跳水,方盛制药跌1.79%","url":"https://stock-news.laohu8.com/highlight/detail?id=2552453596","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552453596?lang=zh_cn&edition=full","pubTime":"2025-07-18 09:49","pubTimestamp":1752803342,"startTime":"0","endTime":"0","summary":"07月18日,千金藤素概念盘中跳水,截至09点48分,千金藤素概念整体指数下跌1.05%,报1087.760点。从个股上来看,该概念的成分股中,方盛制药跌1.79%,华北制药、海王生物、阿拉丁跌幅居前。从资金上来看,截止发稿,千金藤素概念主力净流入为-604.23万,其中皓元医药受到资金热捧,主力净流入591.75万;拉长时间线来看,该板块近20日主力资金净流入7169.77万。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250718094902a452361e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250718094902a452361e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688131","BK0060","BK0191","BK0028","600812","603998","688179","BK0239"],"gpt_icon":0},{"id":"2552848595","title":"方盛制药中标药品阳光采购项目 券商看好买入评级助推股价上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2552848595","media":"自选股中标信息","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552848595?lang=zh_cn&edition=full","pubTime":"2025-07-17 18:31","pubTimestamp":1752748309,"startTime":"0","endTime":"0","summary":"2025年07月17日,据天眼查数据,关于公布药品阳光采购挂网产品的通知显示,中标方为方盛制药,招标方为江苏省公共资源交易中心。近半年内,方盛制药获得2家券商积极评价:开源证券和东吴证券给予\"买入\"评级。方盛制药主营业务涵盖心脑血管疾病用药,骨骼肌肉系统用药,其他,其他收入之和。截至发稿,方盛制药股价报10.63元,上涨0.57%,成交额至2.06亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717183157a450e4b1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717183157a450e4b1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603998"],"gpt_icon":0},{"id":"2551196791","title":"方盛制药涨5.13%创近一个月新高 创新转型构筑估值护城河","url":"https://stock-news.laohu8.com/highlight/detail?id=2551196791","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551196791?lang=zh_cn&edition=full","pubTime":"2025-07-16 11:04","pubTimestamp":1752635040,"startTime":"0","endTime":"0","summary":"方盛制药股价今日表现强势,截至11点03分,最新价报10.66元/股,上涨5.13%,创近一个月新高。截至7月16日,方盛制药近5个交易日振幅达5.33%,量比攀升至2.75,显示资金短期博弈加剧。创新转型构筑估值护城河业绩增长与研发投入形成双轮驱动。公司2024年净利润同比增长36%至2.55亿元,心脑血管用药收入占比提升至29.85%,产品结构持续优化。当前市盈率17.13倍,较中药Ⅱ板块均值低约15%,估值优势凸显。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716110403a6ac6646&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716110403a6ac6646&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603998","BK0239","BK0060"],"gpt_icon":0},{"id":"2551119693","title":"眼科医疗概念盘中拉升,方盛制药涨5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2551119693","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551119693?lang=zh_cn&edition=full","pubTime":"2025-07-16 11:03","pubTimestamp":1752635002,"startTime":"0","endTime":"0","summary":"07月16日,眼科医疗概念盘中拉升,截至11点03分,眼科医疗概念整体指数上涨1.03%,报1383.260点。从个股上来看,该概念的成分股中,方盛制药涨5.13%,贝达药业、众生药业、马应龙涨幅居前。从资金上来看,截止发稿,眼科医疗概念主力净流入为1.77亿,其中众生药业受到资金热捧,主力净流入8384.23万;拉长时间线来看,该板块近20日主力资金净流入-18.08亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716110322a6ac65fc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716110322a6ac65fc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0028","603998","BK0239","BK0096","600993","BK0188","BK0060"],"gpt_icon":0},{"id":"2551159341","title":"千金藤素概念盘中拉升,理邦仪器涨4.82%","url":"https://stock-news.laohu8.com/highlight/detail?id=2551159341","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551159341?lang=zh_cn&edition=full","pubTime":"2025-07-16 09:42","pubTimestamp":1752630146,"startTime":"0","endTime":"0","summary":"07月16日,千金藤素概念盘中拉升,截至09点42分,千金藤素概念整体指数上涨0.53%,报1078.930点。从个股上来看,该概念的成分股中,理邦仪器涨4.82%,优宁维、方盛制药涨幅居前。从资金上来看,截止发稿,千金藤素概念主力净流入为54.07万,其中理邦仪器受到资金热捧,主力净流入823.96万;拉长时间线来看,该板块近20日主力资金净流入592.10万。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071609422697a7c937&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071609422697a7c937&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["300206","BK0060","BK0114","603998","BK0251","BK0239","BK0146"],"gpt_icon":0},{"id":"2551978084","title":"千金藤素概念盘中拉升,步长制药涨3.55%","url":"https://stock-news.laohu8.com/highlight/detail?id=2551978084","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551978084?lang=zh_cn&edition=full","pubTime":"2025-07-14 10:53","pubTimestamp":1752461630,"startTime":"0","endTime":"0","summary":"07月14日,千金藤素概念盘中拉升,截至10点53分,千金藤素概念整体指数上涨1.07%,报1081.020点。从个股上来看,该概念的成分股中,步长制药涨3.55%,华北制药、皓元医药、方盛制药涨幅居前。从资金上来看,截止发稿,千金藤素概念主力净流入为5634.63万,其中皓元医药受到资金热捧,主力净流入2198.86万;拉长时间线来看,该板块近20日主力资金净流入-1.99亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507141053509541832f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507141053509541832f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688131","BK0028","BK0191","603858","BK0239","BK0196","603998","600812"],"gpt_icon":0},{"id":"2550299546","title":"华创医药投资观点&研究专题周周谈第134期:中药企业的创新布局","url":"https://stock-news.laohu8.com/highlight/detail?id=2550299546","media":"华创证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550299546?lang=zh_cn&edition=full","pubTime":"2025-07-12 00:00","pubTimestamp":1752249600,"startTime":"0","endTime":"0","summary":"本周,中信医药指数上涨1.80%,跑赢沪深300指数0.98个百分点,在中信30个一级行业中排名第16位。本周涨幅前十名股票为前沿生物-U、美迪西、联环药业、康辰药业、启迪药业、华纳药厂、浩欧博、塞力医疗、福瑞股份、广生堂。本周跌幅前十名股票ST未名、神州细胞、舒泰神、一品红、海辰药业、华海药业、美诺华、永安药业、荣昌生物、创新医疗。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250712112220a445eec5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250712112220a445eec5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["399275","600572","605199","600535","BK0239","603439","600285","600436","603567","159377","600252","603858","603998","600332","600080","603896","600750","600222","600557","600129","600351","603139","600771","600566","600976","600993","600518","600594","600479","600671"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1754023915598,"stockEarnings":[{"period":"1week","weight":0.0518},{"period":"1month","weight":0.1427},{"period":"3month","weight":0.1938},{"period":"6month","weight":0.2242},{"period":"1year","weight":0.0835},{"period":"ytd","weight":0.1195}],"compareEarnings":[{"period":"1week","weight":-0.009},{"period":"1month","weight":0.0334},{"period":"3month","weight":0.0897},{"period":"6month","weight":0.0992},{"period":"1year","weight":0.2159},{"period":"ytd","weight":0.0661}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"湖南方盛制药股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"33028人(较上一季度增加36.13%)","perCapita":"13294股","listingDate":"2014-12-05","address":"湖南省长沙市岳麓区高新区麓松路789号","registeredCapital":"43908万元","survey":" 湖南方盛制药股份有限公司的主营业务是从事医药产品的研发、生产和销售。公司的主要产品是心脑血管疾病用药、抗感染用药、呼吸系统用药、儿童用药、妇科疾病用药、骨骼肌肉系统用药。公司先后获评:国家火炬计划重点高新技术企业、国家级守合同重信用企业、国家博士后科研工作站、国家企业技术中心、湖南省示范性医药企业、湖南省小巨人计划企业;荣获“国家绿色工厂”称号。","listedPrice":14.85},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.4","shortVersion":"4.34.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"方盛制药(603998)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供方盛制药(603998)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"方盛制药,603998,方盛制药股票,方盛制药股票老虎,方盛制药股票老虎国际,方盛制药行情,方盛制药股票行情,方盛制药股价,方盛制药股市,方盛制药股票价格,方盛制药股票交易,方盛制药股票购买,方盛制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"方盛制药(603998)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供方盛制药(603998)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}